Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.
| Website: | www.minervaneurosciences.com |
| Email: | wboni@minervaneurosciences.com |
| Main Phone: | +1 617 600-7373 |
| Address: | 1601 Trapelo Road |
| Address 2: | Suite 286 |
| State: | MA |
| City / Town: | Waltham |
| Country: | USA |
| Postal Code: | 02451 |
| Exchange: | NSD |
| CEO: | Remy Luthringer |
| Employees: | 12 |
| NAICS: | Pharmaceutical Preparation Manufacturing (325412) |
| Last Price 8.10 | Change $ -0.05 | Change % -0.61 | Tick N/A |
| Bid 5.15 | Bid Size 100.00 | Ask 9.05 | Ask Size 300.00 |
| Open 8.10 | High 8.15 | Low 7.93 | Prev Close 8.15 |
| Last Trade | Volume 64,171 | 52 Wk Hi 9.25 | 52 Wk Low 4.80 |
| Market Cap 313.9 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 38,749,343.00 | EPS (TTM) -0.86 | PE Ratio N/A | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 8 |
| Number of Buys | 0 | 4 |
| Number of Sells | 0 | 4 |
| Net Activity | 0 | 32410 |
| Last 10 Buys | Shares |
|---|---|
| Marc D. Beer | 1,000 |
| Marc D. Beer | 1,000 |
| David J. Kupfer | 1,000 |
| David J. Kupfer | 1,000 |
| David J. Kupfer | 1,000 |
| Francesco De Rubertis | 1,000 |
| Michèle Ollier | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Remy Luthringer | 1,000 |
| Frederick W. Ahlholm | 1,000 |
| Joseph Reilly | 1,000 |
| Geoff Race | 1,000 |
| Mark S. Levine | 1,000 |
| Frederick W. Ahlholm | 1,000 |
| Frederick W. Ahlholm | 1,000 |
| Remy Luthringer | 1,000 |
| Geoff Race | 1,000 |
| Remy Luthringer | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 18 | 18 | 18 | 18 |
| Low Target Price Estimate | 11 | 11 | 11 | 11 |
| Mean Target Price Estimate | 14.5 | 14.5 | 14.5 | 14.5 |
| Standard Deviation | 4.95 | 4.95 | 4.95 | 4.95 |
| Date of Most Recent Estimate | 03/12/18 | 03/12/18 | 03/12/18 | 03/12/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-11 |
| 8-K | Report of unscheduled material events or corporate changes. | 22 | 2018-06-11 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 34 | 2018-05-03 |
| DEFA14A | Additional proxy soliciting materials - definitive | 5 | 2018-04-24 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 66 | 2018-04-24 |
| 8-K | Report of unscheduled material events or corporate changes. | 33 | 2018-03-22 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
